@FierceBiotech: Scripps investigators ID a key player in disarming chemotherapy. FierceBiotechResearch story | Follow @FierceBiotech
@JohnCFierce: Bristol-Myers forges a billion-dollar cancer vaccine deal with Bavarian Nordic. News | Follow @JohnCFierce
@DamianFierce: Alkahest, a @JNJInnovation incuabatee, signed a $50M deal with Grifols. Release | Follow @DamianFierce
> As head of oncology R&D at GlaxoSmithKline ($GSK), Rafael Amado became a passionate supporter of Adaptimmune's R&D strategy for TCRs, genetically reengineering T cells to attack cancer in a field closely related to CAR-Ts. Amado played a lead role in establishing a major, $350 million-plus partnership with the U.K. biotech last year. Now, with GSK completing its deal to flip its cancer drug portfolio to Novartis ($NVS), Amado has jumped to the biotech as its new chief medical officer. Adrian Rawcliffe has joined Adaptimmune as CFO. Release (PDF)
> Belgium's arGEN-X says it has inlicensed a preclinical checkpoint inhibitor and added it to the pipeline. ARGX-115 targets GARP, a novel checkpoint target. Release
> Australian penny stock company Novogen ($NVGN) got a boost after it touted a recent study that may have demonstrated that its lead drug demonstrated some potential in fighting brain cancer. Release
Medical Device News
@FierceMedDev: ICYMI yesterday: Nevro appoints former JJDC head to board as it awaits anticipated FDA approval. Article | Follow @FierceMedDev
@VarunSaxena2: FDA requires new labeling on insulin pens to ward off spread of infections. More from FierceDrugDelivery | Follow @VarunSaxena2
@EmilyWFierce: Pharma CMO? Meet your CIO--and start working together already. FiercePharmaMarketing article | Follow @EmilyWFierce
> Studies show need to supplement mammography with MRI, ultrasound for dense breast tissue. News
> Intuitive Surgical returns to the battlefield with $430M DOD contract. Article
> S&N falls on Stryker buyback plan, buys into Latin American distributor. Story
Pharma News
@FiercePharma: Pfizer shuttering vitamin C plant in California, 70 workers out of jobs. FiercePharmaManufacturing story | Follow @FiercePharma
@EricPFierce: UK starts on $85M cell manufacturing facility as report shows country has become net importer of drugs. More from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Merck's Rebif held its own in last year's MS market shakeup. What about 2015? More | Follow @CarlyHFierce
> FDA calls for heart, stroke warnings on 'Low T' meds. Report
> Takeda's Weber must execute now that he is CEO. Article
Drug Delivery News
> Chrono Therapeutics ropes in new funds from Rock Health for smoking cessation device. Story
> Forbes gives drug delivery a shoutout, says it can make good drugs great. Item
> FDA requires new labeling on insulin pens to ward off spread of infections. Article
> Amgen launches delivery device for automatic administration of its blockbuster Neulasta. News
> Evidence that inhaled oxytocin improves social behavior among autistic patients spurs R&D. More
Diagnostics News
> FDA grants emergency use authorization to Corgenix's fast acting Ebola diagnostic. Article
> RainDance waltzes toward $60M IPO. News
> Skin test could vastly simplify diagnosis of Alzheimer's and Parkinson's. More
> Exact Sciences beefs up sales and reimbursement efforts for colon cancer Dx. Story
> Vigilant Biosciences reels in $5.5M for oral cancer test. Report
Pharma Marketing News
> The long, strange story of Cubist's Cards Against Biotechnology. Feature
> Goldman cuts Afrezza sales forecast in half on slow uptake, pricing pressure. Report
> Surprise: Obesity med Contrave might help CV outcomes. Too bad Orexigen blabbed it. More
> The PD-1 wave? Report says it's a $33B tsunami, with BMS surfing for first place. Story
> Pharma CMO? Meet your CIO--and start working together already. Article